Shandong Shanda Wit Science and Technology Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shandong Shanda Wit Science and Technology Co Ltd with three other
companies in this sector in China:
Jiang Zhong Pharmaceutical Co Ltd
sales of 1.75 billion Chinese Renmimbi [US$258.36 million]
of which 99%
was Medical Industry),
Mayinglong Pharmaceutical Group Co Ltd
(1.75 billion Chinese Renmimbi [US$258.97 million]
of which 64%
was Pharmaceutical Industry), and
Shanghai Shenqi Pharmaceutical Investment Management CoLtd
(1.74 billion Chinese Renmimbi [US$256.76 million]
of which 73%
During the year ended December of 2017, sales at
Shandong Shanda Wit Science and Technology Co Ltd were 1.77 billion Chinese Renmimbi (US$261.43 million).
increase of 14.5%
versus 2016, when the company's sales were 1.54 billion Chinese Renmimbi.
Sales of Medicines saw an increase
that was more than double the company's growth rate: sales were up
35.7% in 2017, from
880.45 million Chinese Renmimbi to 1.19 billion Chinese Renmimbi.
Shandong Shanda Wit Science and Technology Co Ltd also saw significant increases in sales in
Road (up 28.7% to 108.40 million Chinese Renmimbi)
Not all segments of Shandong Shanda Wit Science and Technology Co Ltd experienced an increase in sales in 2017:
sales of Environment Control fell 35.9% to 242.09 million Chinese Renmimbi.